Ebola vaccine developed by Canada okayed for Congo

Adjust Comment Print

Concise News gathered that the outbreak was first confirmed by the organisation on May 8 with the two cases occurring at Bikoro health zone, Equateur province.

Congo has requested that the World Health Organization (WHO) send 4,000 doses of the vaccine and they are expected to arrive by the end of the week.

According to both Stat and Reuters, the DRC granted the World Health Organization approval to use the investigational recombinant vesicular stomatitis virus-Zaire Ebola virus (rVSV-ZEBOV) in a ring vaccination targeting close contacts of Ebola patients. The idea is to vaccinate people who know someone who has been infected and the people who know those people, in an expanding "ring" around the infections.

An air bridge for supplies and personnel will be established by the United Nations Humanitarian Air Service (UNHAS) starting 13 May with daily flights scheduled from Kinshasa to Mbandaka and Mbandaka to Bikoro. Seventeen of those 21 infected people died. Three health care workers are among the cases and one has died.

Despite its isolation, the outbreak's epicenter is just three hours by road to a city of 1 million people, and public health officials are concerned it could spread, The New York Times reports. Contact tracing efforts are already underway. Health officials are following up with almost 400 people identified as contacts of Ebola patients.

Man Killed in Late-Night Palmdale Shooting
McDonnell said it is unclear whom the suspect was aiming at, stating that he "fired the rounds and deliberately left the campus". Meanwhile Antelope Valley Hospital was told several people were dead and as many as 25 students were injured, said Dr.

But it's still very worrisome, said Dr. Peter Salama, WHO's deputy director general for emergency preparedness and response.

Meanwhile, the Nigeria Football Federation (NFF) has said that Nigeria's friendly match against the DR Congo is not under threat in spite of the Ebola outbreak in the country.

The vaccine was developed by the Canadian government and its production has been licensed to Merck in the U.S. Although it was designed and found to be highly effective for a different strain of the virus, it is still considered to be safe and effective.

"We have agreement, registration, plus import permit, everything formally agreed already", WHO Director-General Tedros Adhanom Ghebreyesus told reporters on Monday, adding all is ready now to really use it and vaccinations could begin by next Monday.

Medical officers have been deployed at the airport to screen all passengers coming into the country, especially those from neighboring DRC where there is an Ebola outbreak. The virus spreads through bodily fluids, including vomit and blood.